bpc-157 safety human trials FDA advisory committee votes to add popular peptide to drug compounding list Is BPC‑157 a Risk? Safety,

PMID: 222 GuoZHeKPangKYangDLyuCXuHet al

What Reclassification Would (and Would Not) Change If BPC-157 is moved to Category 1 after the July 2026 meeting, the regulatory impact is narrower than many online summaries suggest: Scenario Category 2 (current default) Category 1 (post-reclassification) FDA approval No No 503A compounding Not permitted Permitted (pending final rulemaking) 503B outsourcing facilities Separate list (503B bulks list) Separate determination required Commercial drug product Not available Still not available without NDA Research/laboratory use Legal for research Legal for research (unchanged) In plain terms: Category 1 status lets a patient with a valid prescription get BPC-157 prepared by a state-licensed compounding pharmacy

They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease or medical condition

Tissue distribution 5

Call your primary care physician or your local pharmacy to find out what your state or local requirements are for disposing of used syringes and needles